Skip to content

Bioavailability of Red Wine Anthocyanins

Bioavailability of Table Red Wine and Young Port Red Wine Anthocyanins

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02975856
Enrollment
6
Registered
2016-11-29
Start date
2015-12-31
Completion date
2016-07-31
Last updated
2016-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Anthocyanins, Bioavailability, Flavonoids, Port wine, Red wine

Brief summary

The main aim of this study is to evaluate the bioavailability of table red wine and young Port red wine anthocyanins in healthy men.

Detailed description

Anthocyanins (ANT) are water soluble pigments found in plants, flowers and fruits that are consumed as part of the human diet, many times in higher amounts than other flavonoid classes. Red wine is also an important source of anthocyanins, especially Mv3glc. Several epidemiological studies have suggested that the consumption of anthocyanin-rich foods, including the moderate consumption of red wine, is positively associated with the prevention of cardiovascular heart disease. It has become clear that the flavonoid bioactive forms in vivo are not necessarily those which occur in nature, but metabolites arising after absorption takes place.Therefore, studying the bioavailability of red wine ANT is very important to identify which metabolites (originated in vivo) can actually reach the target organs (and in which concentrations) and may be responsible for the postulated health benefits of red wine. Intervention protocol: Urine samples and peripheral venous blood (10 ml) will be collected from 10 h-fasting subjects. Afterwards, each volunteer will consume 250 ml of table red wine or 150 ml of young Port red wine and blood samples will be collected 15, 30, 60 and 120 min after wines ingestion. Another urine sample will be collected at 120 min. Table red wine 12 % (250 ml) and young Port red wine 20 % (150 ml), two different food matrices rich in ANT, provided the same amount of ethanol (24 g of ethanol). A thorough screening analysis for ANT will be performed in plasma and urine samples collected from the volunteers at different time points.

Interventions

DIETARY_SUPPLEMENTTable Red Wine
DIETARY_SUPPLEMENTYoung Port Red Wine

Sponsors

REQUIMTE/LAQV, Departamento de Química e Bioquímica, FCUP
CollaboratorUNKNOWN
Center for Health Technology and Services Research
CollaboratorOTHER
Vinoflavo
CollaboratorINDUSTRY
Universidade do Porto
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Men * Age 18-65 years * BMI \< 25 kg/m2 * Willing and able to provide written consent

Exclusion criteria

* Subjects with current or previous CVD, diabetes or other severe chronic disease * Subjects under prescription of any chronic medication * Intake of red fruits or red wine in the last 24 h prior to the beginning of the intervention * Subjects involved in any clinical or food study within the preceding month

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of anthocyanins and anthocyanins metabolitesAt baseline and 15, 30, 60 and 120 minutes after wines consumption

Secondary

MeasureTime frame
Urinary concentrations of anthocyanins and anthocyanins metabolitesAt baseline and 120 minutes after wines consumption

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026